Polar Capital Holdings Plc 13D and 13G filings for Avadel Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 5:58 pm Sale | 2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL | Polar Capital Holdings Plc | 4,803,899 4.990% | -1,947,883 (-28.85%) | Filing |
| 2024-02-13 09:40 am Purchase | 2023-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Polar Capital Holdings Plc | 6,751,782 7.510% | 3,957,109 (+141.59%) | Filing |
| 2022-02-14 10:40 am Sale | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Polar Capital Holdings Plc | 2,794,673 4.800% | -233,032 (-7.70%) | Filing |
| 2021-02-16 07:32 am Purchase | 2020-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Polar Capital Holdings Plc | 3,027,705 5.200% | 3,027,705 (New Position) | Filing |